Position statement for the use of complementary and alternative medicines
This position statement provides guidance on the management and use of complementary and alternative medicines (CAM), which are not listed…
Managing medication samples
Guiding Principles on using medication samples in Australian public hospitals. This document, updated in 2022, provides guidance to Drug and…
Facilitating the translation of evidence into best practice: Optimising the pharmacological management of inflammatory arthritis
Navigating high-cost medicines
These Guiding Principles provide a principles based high level framework outlining national objectives to assist medicines governance committees, including Drugs…
Therapeutic drug monitoring in inflammatory bowel disease
CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management…
Biologics and biosimilars best practice
These Guiding Principles provide a national approach to the governance of biologics and their biosimilars. They assist those responsible for…
Optimising My Health Record utilisation
The Position statement supports the use of the My Health Record (MHR) in Australian public hospitals as a tool to…
Supporting safe practices for low-dose methotrexate
This position statement aims to provide clear information on safety for those dispensing and administering low-dose methotrexate (oral and subcutaneous…
Managing Medicines Access Programs
This document provides guidance to Drug and Therapeutics Committees (DTCs) or equivalent, hospital policy makers and health professionals on the…
Rethinking medicines decision-making in Australian Hospitals
These Guiding Principles provide a framework to support the quality use of off-label medicines in Australian public hospitals. These principles…